1887
  1. Home
  2. Eurosurveillance
  3. Volume 26, Issue 27, 08/Jul/2021
  4. Article
Rapid communication Open Access
Like 0
Download

Abstract

We investigated a COVID-19 outbreak of the SARS-CoV-2 Delta variant of concern in a London care home, where 8/21 residents and 14/21 staff had received a single dose of Vaxzevria (ChAdOx1-S; AstraZeneca) vaccine. We identified 24 SARS-CoV-2 infections (16 residents, 8 staff) among 40 individuals (19 residents, 21 staff); four (3 residents, 1 staff) were hospitalised, and none died. The attack rate after one vaccine dose was 35.7% (5/14) for staff and 81.3% (13/16) for residents.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2021.26.27.2100626
2021-07-08
2025-04-30
/content/10.2807/1560-7917.ES.2021.26.27.2100626
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/26/27/eurosurv-26-27-3.html?itemId=/content/10.2807/1560-7917.ES.2021.26.27.2100626&mimeType=html&fmt=ahah

References

  1. Dunn P, Allen L, Cameron G, Malhotra AM, Alderwick H. COVID-19 policy tracker 2020. London: The Health Foundation; 2021. Available from: https://www.health.org.uk/news-and-comment/charts-and-infographics/covid-19-policy-tracker
  2. National Health System Test and Trace. Care home COVID-19 testing guidance: for testing of staff and residents. London: United Kingdom Government; 2021. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/988099/Care_Home_Testing_Guidance_England_v12-03_rev4_DIGITAL.pdf
  3. Public Health England (PHE). Evaluation of Roche Elecsys Anti-SARS-CoV-2 S serology assay for the detection of anti-SARS-CoV-2 S antibodies. London: PHE; 2021. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/989460/Evaluation_of_Roche_Elecsys_anti_SARS_CoV_2_S_assay_PHE.pdf
  4. Public Health England (PHE). Evaluation of Roche Elecsys Anti-SARS-CoV-2 serology assay for the detection of anti-SARS-CoV-2 antibodies. London: PHE; 2020. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/891598/Evaluation_of_Roche_Elecsys_anti_SARS_CoV_2_PHE_200610_v8.1_FINAL.pdf
  5. The Public Health England (PHE) Variant Technical Group. SARS-CoV-2 variants of concern and variants under investigation in England: Technical briefing 10. London: PHE. [Accessed: 15 Jun 2021]. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/984274/Variants_of_Concern_VOC_Technical_Briefing_10_England.pdf
  6. Patel MC, Chaisson LH, Borgetti S, Burdsall D, Chugh RK, Hoff CR, et al. Asymptomatic SARS-CoV-2 infection and COVID-19 mortality during an outbreak investigation in a skilled nursing facility. Clin Infect Dis. 2020;71(11):2920-6.  https://doi.org/10.1093/cid/ciaa763  PMID: 32548628 
  7. McMichael TM, Currie DW, Clark S, Pogosjans S, Kay M, Schwartz NG, et al. Epidemiology of Covid-19 in a long-term care facility in King County, Washington. N Engl J Med. 2020;382(21):2005-11.  https://doi.org/10.1056/NEJMoa2005412  PMID: 32220208 
  8. Public Health England (PHE). COVID-19: the green book, chapter 14a. London, PHE. [Accessed: 11 Jun 2021]. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/984310/Greenbook_chapter_14a_7May2021.pdf
  9. United States Food and Drug Administration (FDA). Pfizer-BioNTech COVID-19 vaccine emergency use authorization review memorandum. Silver Spring: FDA; 2020. Available from: https://www.fda.gov/media/144416/download
  10. Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603-15.  https://doi.org/10.1056/NEJMoa2034577  PMID: 33301246 
  11. Voysey M, Costa Clemens SA, Madhi SA, Weckx LY, Folegatti PM, Aley PK, et al. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet. 2021;397(10277):881-91.  https://doi.org/10.1016/S0140-6736(21)00432-3  PMID: 33617777 
  12. Lopez Bernal J, Andrews N, Gower C, Robertson C, Stowe J, Tessier E, et al. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. BMJ. 2021;373(1088):n1088.  https://doi.org/10.1136/bmj.n1088  PMID: 33985964 
  13. Vasileiou ESC, Simpson CR, Robertson C, Shi T, Kerr S, Agrawal U, et al. Effectiveness of First Dose of COVID-19 Vaccines Against Hospital Admissions in Scotland: National Prospective Cohort Study of 5.4 Million People. 2021. https://doi.org/DOI:10.2139/ssrn.3789264
  14. Shrotri M, Krutikov M, Palmer T, Giddings R, Azmi B, Subbarao S, et al. Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of Long-Term Care Facilities (VIVALDI study). medRxiv. 2021.03.26.21254391.  https://doi.org/10.1101/2021.03.26.21254391 
  15. Bernal JL, Andrews N, Gower C, Gallagher E, Simmons R, Thelwall S, et al. Effectiveness of COVID-19 vaccines against the B.1.617.2 variant. medRxiv. 2021:2021.05.22.21257658.  https://doi.org/10.1101/2021.05.22.21257658 
  16. Stowe J, Andrews N, Gower C, Gallagher E, Utsi L, Simmons R, et al. Effectiveness of COVID-19 vaccines against hospital admission with the Delta (B.1.617.2) variant. London: Public Health England; 2021. Pre-print. Available from: https://khub.net/web/phe-national/public-library/-/document_library/v2WsRK3ZlEig/view/479607266
  17. Public Health England (PHE). Variants: distribution of case data, 11 June 2021. London: United Kingdom Government; 2021. Available from: https://www.gov.uk/government/publications/covid-19-variants-genomically-confirmed-case-numbers/variants-distribution-of-case-data-11-june-2021
  18. Department of Health and Social Care. Adult social care monthly statistics, England: May 2021. London: United Kingdom Government; 2021. Available from: https://www.gov.uk/government/statistics/adult-social-care-in-england-monthly-statistics-may-2021/adult-social-care-monthly-statistics-england-may-2021
An outbreak caused by the SARS-CoV-2 Delta (B.1.617.2) variant in a care home after partial vaccination with a single dose of the COVID-19 vaccine Vaxzevria, London, England, April 2021
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Sarah+V+Williams&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Williams Sarah V</a>, <a href="/search?value1=Amoolya+Vusirikala&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Vusirikala Amoolya</a>, <a href="/search?value1=Shamez+N+Ladhani&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Ladhani Shamez N</a>, <a href="/search?value1=Elena+Fernandez+Ruiz+De+Olano&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Fernandez Ruiz De Olano Elena</a>, <a href="/search?value1=Nalini+Iyanger&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Iyanger Nalini</a>, <a href="/search?value1=Felicity+Aiano&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Aiano Felicity</a>, <a href="/search?value1=Kelly+Stoker&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Stoker Kelly</a>, <a href="/search?value1=Guduru+Gopal+Rao&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Gopal Rao Guduru</a>, <a href="/search?value1=Laurence+John&option1=author&noRedirect=true" class="nonDisambigAuthorLink">John Laurence</a>, <a href="/search?value1=Bharat+Patel&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Patel Bharat</a>, <a href="/search?value1=Nick+Andrews&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Andrews Nick</a>, <a href="/search?value1=Gavin+Dabrera&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Dabrera Gavin</a>, <a href="/search?value1=Mary+Ramsay&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Ramsay Mary</a>, <a href="/search?value1=Kevin+E+Brown&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Brown Kevin E</a>, <a href="/search?value1=Jamie+Lopez+Bernal&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Lopez Bernal Jamie</a>, <a href="/search?value1=Vanessa+Saliba&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Saliba Vanessa</a></span>. An outbreak caused by the SARS-CoV-2 Delta (B.1.617.2) variant in a care home after partial vaccination with a single dose of the COVID-19 vaccine Vaxzevria, London, England, April 2021. <a href="/content/ecdc">Euro Surveill.</a> 2021;26(27):pii=2100626. <a href="https://doi.org/10.2807/1560-7917.ES.2021.26.27.2100626" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2021.26.27.2100626</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 22 Jun 2021;&nbsp;&nbsp; <span class="generated">Accepted</span>: 07 Jul 2021 </span> </p>
/content/10.2807/1560-7917.ES.2021.26.27.2100626
/content/10.2807/1560-7917.ES.2021.26.27.2100626
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error